Home Data Calendar Blog

SRDX

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Common Stock Value 0.710.710.710.710.700.700.700.700.690.690.690.690.680.680.680.680.680.680.670.670.670.670.660.660.660.660.660.660.660.650.650.650.650.650.650.650.680.680.680.680.690.710.730.730.730.880.880.880.880.88NANA0.87NA
Weighted Average Number Of Diluted Shares Outstanding NA14.0714.0313.98NA13.9313.9213.88NA13.8413.9813.67NA13.7913.7513.77NA13.7313.7913.83NA13.2013.4613.06NA13.3813.4313.45NA13.2813.1913.19NA13.2813.2113.42NA13.8113.8214.01NA14.7414.9114.86NA17.6517.6317.53NA17.5317.4717.40NA17.36
Weighted Average Number Of Shares Outstanding Basic NA14.0514.0313.98NA13.9313.9213.88NA13.8413.7513.67NA13.6013.5113.47NA13.3913.3913.37NA13.2013.1013.06NA13.1513.2213.20NA12.9912.9712.97NA13.0012.9413.22NA13.5913.5413.76NA14.4114.6214.65NA17.5317.5217.48NA17.4417.4117.38NA17.36
Earnings Per Share Basic 0.480.52-0.55-0.56-1.06-0.41-0.29-0.20-0.02-0.240.59-0.02-0.220.180.110.010.270.110.090.10-0.13-0.200.12-0.120.030.050.040.170.200.310.060.190.100.300.240.270.170.260.180.260.160.220.280.290.160.170.100.15-1.070.220.14-0.36-1.24-0.05
Earnings Per Share Diluted 0.480.52-0.55-0.56-1.06-0.41-0.29-0.20-0.02-0.240.58-0.02-0.220.180.110.010.260.110.090.09-0.13-0.200.11-0.120.030.050.040.170.200.300.060.190.100.300.230.270.170.260.180.260.160.210.280.290.160.170.100.15-1.070.220.14-0.35-1.24-0.05

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Revenue From Contract With Customer Excluding Assessed Tax 27.9752.4827.2024.9325.9924.8526.1123.0023.9723.8734.9922.3022.5426.8822.8222.6230.8224.3422.6822.2423.0422.2319.0617.0120.0617.7917.5017.7618.1519.9716.7016.5417.3615.9114.4114.2115.3414.6213.6013.8814.3014.2913.7013.8513.8413.9612.2111.9213.9017.9713.3312.5215.5518.61
Revenues 27.9752.4827.2024.9325.9924.8526.1123.0023.9723.8734.9922.3022.5426.8822.8222.6230.8224.3422.6822.2423.0422.2319.0617.0120.0617.7917.5017.7618.1519.9716.7016.5417.3615.9114.4114.2115.3414.6213.6013.8814.3014.2913.7013.8513.8413.9612.2111.9213.9017.9713.3312.5215.5518.61
Cost Of Goods And Services Sold 7.046.925.745.275.605.145.114.504.165.114.173.743.904.443.773.203.663.363.093.524.094.102.912.893.322.91NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Costs And Expenses 30.4231.0733.7832.1632.6032.0031.0126.4424.4626.2625.5122.2024.5425.7222.9822.8826.9423.3321.8121.5325.4828.4818.5317.6519.6416.0515.8314.4914.0713.3814.4612.6013.1010.0610.489.179.909.2810.129.558.7210.059.578.979.219.178.528.6934.5414.529.128.4033.6416.39
Research And Development Expense Excluding Acquired In Process Cost 9.7011.2312.9212.7412.2612.9713.7111.6610.7312.2512.8810.8812.7913.3211.9412.1414.5213.3213.5511.49NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Selling General And Administrative Expense 12.8112.8712.9713.2413.7812.8511.119.197.867.887.917.027.307.426.736.947.195.944.885.956.505.986.445.195.315.235.084.865.024.484.853.653.684.024.123.693.563.594.293.852.314.053.853.653.753.413.393.475.554.923.473.724.784.94
Operating Income Loss -2.4521.41-6.58-7.23-6.61-7.14-4.90-3.44-0.49-2.389.480.09-1.991.16-0.16-0.273.881.020.860.71-2.44-6.250.53-0.630.411.741.683.274.086.602.243.944.275.863.935.035.435.333.484.334.644.244.134.884.644.793.693.222.933.454.214.12-18.092.22
Interest Expense 0.900.880.880.830.190.140.130.140.130.060.060.060.030.030.030.040.040.040.040.04NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Interest Paid Net 0.760.760.730.660.160.090.080.08NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 1.941.921.781.971.861.801.721.681.541.461.431.431.421.341.301.391.571.320.961.231.511.291.100.900.850.950.880.791.110.831.220.680.540.630.690.530.290.581.650.810.570.740.850.390.540.660.640.891.460.88NANANANA
Income Tax Expense Benefit -9.4813.300.37-0.177.94-1.53-0.92-0.71-0.270.781.440.170.87-1.25-1.95-0.250.56-0.26-0.16-0.18-0.28-2.61-1.221.03-0.210.531.051.731.462.861.361.291.421.931.481.471.861.731.211.471.861.120.921.881.961.761.241.21-4.32-0.081.761.45-1.571.10
Income Taxes Paid Net 2.600.240.010.010.020.000.390.000.120.020.010.010.020.000.000.000.040.010.150.000.020.110.770.010.230.010.980.902.401.832.440.041.861.672.950.031.441.463.280.121.861.313.720.231.670.360.010.021.411.93-2.29-0.040.29NA
Profit Loss 6.697.35-7.73-7.84-14.73-5.65-4.08-2.81-0.29-3.298.09-0.27-2.952.461.460.153.551.471.261.31-1.75-2.681.53-1.560.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Comprehensive Income Loss Net Of Tax -1.560.610.805.26-4.16-4.29-1.51-1.65-1.770.53-1.771.831.710.98-0.941.04-1.580.53-0.74-0.53-0.26-2.231.180.621.402.290.66-2.210.39-0.841.320.410.01-0.03-0.42-1.081.490.05-0.04-0.030.09-0.16-0.150.24-0.100.040.43-0.18NANANANANANA
Net Income Loss 6.697.35-7.73-7.84-14.73-5.65-4.08-2.818.09-3.298.09-0.27-2.952.461.460.153.551.471.261.31-1.75-2.681.53-1.560.400.720.512.302.584.000.822.511.363.923.053.612.343.602.463.632.743.134.104.252.743.061.722.71-18.663.842.49-6.17-21.66-0.92
Comprehensive Income Net Of Tax 5.147.96-6.93-2.59-18.88-9.94-5.59-4.466.31-2.766.311.56-1.243.440.521.181.972.000.520.78-2.02-4.912.71-0.941.803.011.170.093.033.162.152.921.363.892.632.533.843.642.423.603.782.973.954.492.643.102.152.53NANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Assets 185.73188.90166.16169.75158.36175.65184.19184.87194.59177.20177.09163.56168.76166.50155.55155.06159.87150.34150.98150.66164.13159.99163.32134.55136.59131.89131.29128.62132.89126.91122.48112.2298.7195.9990.6987.12104.89100.7295.6895.06101.92103.93107.59107.82103.08157.68154.40151.99162.65173.45NANA170.28NA
Liabilities 65.8276.4963.6162.4949.9750.5450.9248.2054.5136.3735.0130.1537.7135.9130.5831.7337.3531.7135.6737.0455.5251.2449.9624.0125.0422.5421.8821.4426.0624.1123.6516.946.846.265.515.476.146.055.056.118.115.895.619.119.338.028.479.0517.3215.57NANA15.92NA
Liabilities And Stockholders Equity 185.73188.90166.16169.75158.36175.65184.19184.87194.59177.20177.09163.56168.76166.50155.55155.06159.87150.34150.98150.66164.13159.99163.32134.55136.59131.89131.29128.62132.89126.91122.48112.2298.7195.9990.6987.12104.89100.7295.6895.06101.92103.93107.59107.82103.08157.68154.40151.99162.65173.45NANA170.28NA
Stockholders Equity 119.91112.41102.55107.26108.39125.11133.26136.67140.09140.83142.08133.41131.06130.58124.97123.33122.52118.63115.31113.62108.61108.75113.36110.55111.56109.35109.41107.18106.83102.8198.8395.2791.8789.7385.1881.6598.7594.6790.6388.9593.8298.04101.9898.7093.74149.65145.93142.94145.34157.88NANA154.36NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Assets Current 86.6985.8561.2464.4657.5960.0364.6864.9270.2594.1193.0480.8686.6187.8077.3073.4781.4269.5471.5270.6881.5378.8581.3460.0060.8857.6758.3756.6458.5654.0751.7253.2467.7965.3159.7639.0355.2850.8144.6531.8835.7838.3345.7839.8939.9590.8386.8881.2253.7650.60NANA37.48NA
Cash And Cash Equivalents At Carrying Value 41.4244.5819.1826.4319.0020.0724.7126.6531.1562.1848.1635.7530.7936.3915.219.0130.3628.9222.4714.4023.3227.2727.7121.6016.5311.3511.2617.6524.9934.6638.9942.6755.5954.1130.0226.5643.5139.738.4410.5215.4917.7120.5421.4615.5465.8760.1849.3623.2218.4415.4914.3111.398.62
Accounts Receivable Net Current 10.8511.7512.1210.0710.459.3811.048.019.178.609.108.067.678.668.897.688.998.389.319.768.888.317.226.707.216.997.026.506.875.866.935.527.486.004.934.444.755.185.615.115.334.744.914.425.075.184.634.777.699.17NANA8.99NA
Inventory Net 14.8414.6113.7712.7211.8210.939.478.296.766.326.316.265.975.875.744.954.504.154.344.174.023.984.053.873.523.503.353.473.583.353.333.302.983.463.192.832.822.902.762.833.333.213.363.223.523.263.672.974.153.73NANA3.05NA
Inventory Finished Goods NA4.323.423.324.122.732.191.741.301.241.401.181.391.421.221.191.571.381.571.451.351.321.201.081.251.281.101.301.321.721.802.081.722.142.051.731.761.921.721.601.951.982.011.812.041.98NANA1.96NANANANANA
Prepaid Expense And Other Assets Current 7.367.238.318.076.767.657.917.696.453.103.413.553.373.593.744.163.873.233.172.942.463.052.342.491.222.471.541.180.470.691.640.961.200.620.93NA0.69NANANANANANANANANANANANANANANANANA
Available For Sale Securities Debt Securities 3.90NANANA0.002.012.015.699.72NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 56.47NANANA51.32NANANA47.72NANANA42.96NANANA37.99NANANA33.51NANANA29.93NANANA26.98NANANA25.42NANANA24.42NANANA24.35NANANA-22.67NANANA-21.12NANANANANA
Amortization Of Intangible Assets 0.900.900.901.001.001.101.101.201.200.600.600.600.700.600.600.700.600.700.700.700.700.700.700.700.700.600.600.600.500.800.800.350.200.200.200.200.100.200.200.200.100.200.200.20NANANANANANANANANANA
Property Plant And Equipment Net 26.0326.5727.6127.7227.1528.2929.0829.3230.0929.1129.7530.3530.1028.9429.7930.7729.7529.5629.5129.9030.1427.9825.8423.6222.9422.2520.6320.1919.6017.1813.8813.5112.9712.1012.4212.6713.1312.7112.6912.4912.8512.8713.2113.5913.6113.2113.7014.0447.9363.84NANA65.39NA
Goodwill 42.9543.8443.8243.3140.7142.5944.2544.9045.6127.3827.1927.8627.1826.5626.2826.5526.1726.7426.5526.8327.0327.1327.9327.5027.2826.7925.9525.6926.5526.5426.9621.828.018.018.018.018.018.018.018.018.018.018.018.018.018.018.018.018.018.01NANA8.01NA
Intangible Assets Net Excluding Goodwill 26.2127.8028.7329.2628.1430.7533.5135.2437.0511.4812.0312.9513.2812.5913.0413.7914.2315.4816.0216.8717.6818.4319.7320.0820.5621.2321.1221.0922.5222.8924.0616.502.762.392.572.762.953.133.323.503.693.874.064.254.43NANANANANANANANANA
Finite Lived Intangible Assets Net 25.6327.2228.1528.6827.5730.1732.9334.6636.47NANANANANANANANANANANANANANANANANANANANANANANANANANA2.762.953.133.323.503.69NANANA4.434.624.804.9910.6314.10NANA15.26NA
Other Assets Noncurrent 3.864.844.765.014.775.515.494.123.724.704.514.534.275.024.364.122.122.962.081.601.451.621.201.040.900.880.730.720.630.670.670.650.481.981.981.981.983.173.173.173.173.153.153.032.832.993.023.003.544.90NANA5.24NA
Available For Sale Debt Securities Amortized Cost Basis 3.94NANANANA2.022.025.709.72NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Liabilities Current 23.9532.0519.1317.2632.0829.3928.3725.6429.8217.6615.7012.4518.8915.6313.2814.1920.2117.2320.3420.4235.1331.5934.2319.539.807.546.745.9310.138.078.315.614.704.253.553.544.074.123.244.325.983.803.476.936.905.475.886.4711.047.52NANA7.65NA
Accounts Payable Current 2.992.483.792.043.141.932.111.841.781.521.590.861.511.381.662.402.082.533.752.752.551.672.012.312.401.921.821.611.621.552.081.050.780.961.141.531.031.401.091.370.950.740.970.941.660.741.500.882.421.61NANA3.34NA
Other Accrued Liabilities Current 0.540.370.500.360.550.540.540.340.414.304.164.095.554.704.644.884.793.865.105.056.264.264.021.791.831.211.531.561.111.491.431.531.101.110.951.060.880.840.771.201.150.870.881.371.070.830.971.801.931.83NANA1.75NA
Accrued Income Taxes Current NA11.950.04NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Accrued Liabilities Current 6.445.456.467.055.855.866.556.084.91NANANA5.55NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Long Term Debt 29.4129.3529.3029.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Long Term Debt Noncurrent NANANA29.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Deferred Income Tax Liabilities Net 2.002.062.022.102.032.232.372.552.74NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Liabilities Noncurrent 8.069.549.749.5210.7711.5211.7610.7111.657.677.557.638.027.877.446.635.514.754.855.715.725.681.922.062.121.841.941.882.151.901.901.821.921.781.741.721.841.781.651.641.971.921.962.002.252.352.392.372.684.39NANA4.67NA
Operating Lease Liability Noncurrent 2.973.063.323.583.844.104.303.263.193.323.293.413.34NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Stockholders Equity 119.91112.41102.55107.26108.39125.11133.26136.67140.09140.83142.08133.41131.06130.58124.97123.33122.52118.63115.31113.62108.61108.75113.36110.55111.56109.35109.41107.18106.83102.8198.8395.2791.8789.7385.1881.6598.7594.6790.6388.9593.8298.04101.9898.7093.74149.65145.93142.94145.34157.88NANA154.36NA
Common Stock Value 0.710.710.710.710.700.700.700.700.690.690.690.690.680.680.680.680.680.680.670.670.670.670.660.660.660.660.660.660.660.650.650.650.650.650.650.650.680.680.680.680.690.710.730.730.730.880.880.880.880.88NANA0.87NA
Additional Paid In Capital Common Stock 36.7134.3432.4530.2228.7726.6124.8322.6421.6020.0218.5216.1615.3713.6611.4810.3610.748.837.516.347.615.735.435.345.415.008.077.016.755.764.953.543.062.281.620.732.662.422.03NA2.0310.0116.9118.8218.3576.7576.1375.3074.4973.37NANA69.70NA
Retained Earnings Accumulated Deficit 87.2580.5673.2280.9588.79103.52109.17113.25116.06116.35119.64111.55111.83114.77112.31110.85110.70107.15105.69104.4297.6199.37102.05100.52102.07101.67100.95100.4598.1595.5091.5090.6788.1686.8082.8879.8393.8891.5487.9488.2491.0487.3584.2278.8774.6271.8968.8267.1070.1283.06NANA82.90NA
Accumulated Other Comprehensive Income Loss Net Of Tax -4.76-3.20-3.81-4.62-9.87-5.72-1.430.071.733.763.235.013.171.470.491.430.401.981.442.182.722.985.214.033.422.02-0.27-0.941.270.891.730.410.01-0.000.030.451.530.04-0.010.030.06-0.030.130.280.040.140.10-0.33-0.150.57NANA0.89NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1.941.921.781.971.861.801.721.681.541.461.431.431.421.341.301.391.571.320.961.231.511.291.100.90NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Operating Activities 1.2525.89-5.83-10.80-2.50-3.50-4.20-7.030.892.7516.02-4.271.3111.442.17-0.9112.52-0.541.47-5.414.831.7926.820.616.40NANANANANANANANANANANANANANANANANANANA5.645.814.231.944.930.887.426.725.29NA
Net Cash Provided By Used In Investing Activities -4.65-0.47-0.72-0.981.43-0.862.443.22-41.8811.17-4.409.87-7.208.885.25-16.00-11.476.956.437.84-9.270.12-20.095.74-0.94NANANANANANANANANANANANANANANANANANANA-1.040.146.0724.44-0.261.96-6.56-3.81-1.80NA
Net Cash Provided By Used In Financing Activities 0.42-0.02-0.7918.800.30-0.01-0.04-0.6210.030.060.93-0.790.160.84-1.18-4.460.450.000.21-11.690.50-2.21-0.70-0.97-0.46NANANANANANANANANANANANANANANANANANANA-54.93-0.040.15-0.110.100.100.34-0.00-0.72NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Operating Activities 1.2525.89-5.83-10.80-2.50-3.50-4.20-7.030.892.7516.02-4.271.3111.442.17-0.9112.52-0.541.47-5.414.831.7926.820.616.40NANANANANANANANANANANANANANANANANANANA5.645.814.231.944.930.887.426.725.29NA
Net Income Loss 6.697.35-7.73-7.84-14.73-5.65-4.08-2.818.09-3.298.09-0.27-2.952.461.460.153.551.471.261.31-1.75-2.681.53-1.560.400.720.512.302.584.000.822.511.363.923.053.612.343.602.463.632.743.134.104.252.743.061.722.71-18.663.842.49-6.17-21.66-0.92
Profit Loss 6.697.35-7.73-7.84-14.73-5.65-4.08-2.81-0.29-3.298.09-0.27-2.952.461.460.153.551.471.261.31-1.75-2.681.53-1.560.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Depreciation Depletion And Amortization 2.162.152.092.122.242.212.322.382.411.841.911.861.871.791.801.801.851.891.821.761.721.601.591.521.551.411.331.281.171.411.390.910.720.690.710.680.660.670.680.700.710.730.720.720.710.730.730.751.750.790.810.801.87NA
Increase Decrease In Inventories 0.230.841.040.910.891.461.141.570.48-0.010.110.240.040.100.820.410.40-0.210.190.160.05-0.040.150.34-0.010.04-0.06-0.070.030.010.010.08-0.480.270.370.01-0.080.14-0.07-0.500.12-0.150.14-0.300.26-0.400.69-0.210.410.580.070.04-0.46NA
Increase Decrease In Accounts Payable 0.49-0.951.53-1.251.26-0.140.290.200.290.280.18-0.480.01-0.36-0.660.53-0.55-1.491.080.19NANA-0.35-0.06NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Deferred Income Tax Expense Benefit 0.010.03-0.11-0.118.26-1.42-0.94-0.640.700.140.500.31-1.73-0.801.58-0.19-0.11-0.77-0.520.31-0.32-2.65-1.011.71-0.951.43-0.220.740.38-2.171.310.75-0.36-0.34-0.231.02-0.250.07-0.560.40-0.53-0.140.140.03-0.18-0.25-0.24-0.06-5.020.690.97-2.53-0.54NA
Amortization Of Financing Costs 0.090.090.100.080.010.010.010.01NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Investing Activities -4.65-0.47-0.72-0.981.43-0.862.443.22-41.8811.17-4.409.87-7.208.885.25-16.00-11.476.956.437.84-9.270.12-20.095.74-0.94NANANANANANANANANANANANANANANANANANANA-1.040.146.0724.44-0.261.96-6.56-3.81-1.80NA
Payments To Acquire Property Plant And Equipment 0.750.470.720.980.570.861.160.782.400.900.651.321.040.320.641.671.861.021.052.072.182.902.721.301.552.021.321.543.323.890.600.381.480.230.120.041.110.370.740.060.470.210.380.860.330.160.110.160.182.030.410.832.48NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Financing Activities 0.42-0.02-0.7918.800.30-0.01-0.04-0.6210.030.060.93-0.790.160.84-1.18-4.460.450.000.21-11.690.50-2.21-0.70-0.97-0.46NANANANANANANANANANANANANANANANANANANA-54.93-0.040.15-0.110.100.100.34-0.00-0.72NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Revenues 27.9752.4827.2024.9325.9924.8526.1123.0023.9723.8734.9922.3022.5426.8822.8222.6230.8224.3422.6822.2423.0422.2319.0617.0120.0617.7917.5017.7618.1519.9716.7016.5417.3615.9114.4114.2115.3414.6213.6013.8814.3014.2913.7013.8513.8413.9612.2111.9213.9017.9713.3312.5215.5518.61
, Secured Term Loan Facilities, Rolling Four Quarter Core Net Revenue, Subsequent Event, Midcap Credit Agreement NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Revenue From Contract With Customer Excluding Assessed Tax 27.9752.4827.2024.9325.9924.8526.1123.0023.9723.8734.9922.3022.5426.8822.8222.6230.8224.3422.6822.2423.0422.2319.0617.0120.0617.7917.5017.7618.1519.9716.7016.5417.3615.9114.4114.2115.3414.6213.6013.8814.3014.2913.7013.8513.8413.9612.2111.9213.9017.9713.3312.5215.5518.61
Operating 27.9752.4827.2024.9325.9924.8526.1123.0023.9723.8734.9922.3022.5426.8822.8222.6230.8224.3422.6822.2423.0422.2319.0617.01NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Operating, Research Development And Other, In Vitro Diagnostics 0.100.100.060.060.050.150.130.540.380.530.710.560.150.140.200.26NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Operating, Research Development And Other, Medical Device 2.462.562.361.872.031.992.172.022.212.472.442.301.942.352.632.233.262.822.812.381.962.15NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Operating, License, Medical Device NA25.931.361.362.261.021.491.211.231.0412.581.431.627.651.511.257.632.021.622.412.381.870.540.03NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Operating, Product, In Vitro Diagnostics 6.836.377.445.856.437.187.525.566.206.596.375.545.226.226.324.955.725.375.334.976.045.525.004.24NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Operating, Product, Medical Device 8.539.307.918.387.966.746.446.796.315.495.414.565.375.765.465.024.784.504.564.784.714.963.693.85NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Operating, Royalty, Medical Device NA8.228.077.417.257.778.366.897.657.757.477.918.254.756.718.909.189.618.317.687.947.737.897.04NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Operating, In Vitro Diagnostics 6.936.477.495.926.497.337.656.096.587.127.096.105.366.376.525.215.975.405.384.986.055.535.014.245.335.014.784.004.454.325.104.294.254.293.853.574.123.793.123.334.003.703.963.323.853.69NANANANANANANANA
Operating, Medical Device 21.0446.0119.7119.0219.5017.5318.4516.9117.3916.7527.9116.2017.1820.5116.3017.4024.8518.9517.3017.2616.9916.7014.0512.7714.7212.7812.7313.7613.7015.6511.6012.2513.1211.6310.5610.6311.2210.8210.4810.5510.3010.599.7310.539.9910.27NANANANANANANANA
Abbott Agreement NANA1.301.302.101.001.401.201.201.0012.501.301.607.601.501.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Abbott Agreement, Royalty NA25.90NANANA1.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Research Development And Other 2.562.662.421.932.082.142.302.562.592.993.162.862.092.502.832.493.302.852.862.392.012.15NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product 15.3615.6715.3514.2314.3913.9213.9612.3412.5112.0811.7810.1010.5911.9911.779.9710.719.879.899.7510.7010.478.698.098.838.33NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Royalty 10.0534.159.438.779.518.799.848.108.878.8020.059.339.8712.408.2210.1516.8111.629.9310.1010.329.608.437.089.227.24NANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Income Loss From Continuing Operations 
Before Income Taxes Extraordinary Items Noncontrolling Interest
Expenses
Income Tax Expense Benefit
Balance Sheet
Operating Lease Liability
Assets
Available For Sale Securities Debt Securities
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Other Accrued Liabilities Current
Noncurrent Liabilities
Deferred Income Tax Liabilities Net
Stockholders Equity
Accumulated Other Comprehensive Income Loss Net Of Tax
CashFlow
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInOperatingActivities
Increase Decrease In Prepaid Deferred Expense And Other Assets
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInFinancingActivities
Proceeds From Issuance Of Long Term Debt
Shares
Weighted Average Number Of Shares Outstanding Basic
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Year Three
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Accumulated Amortization
InventoryNet
Inventory Work In Process Net Of Reserves
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept


Operating Margin
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Operating  Marginus-gaap: Consolidation Items, us-gaap: Statement Business Segments
TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None, 'srdx:InVitroDiagnostics')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Product Or Service, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None, 'srdx:MedicalDevice')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Product Or Service, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:OperatingIncomeLoss
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Operating Income Lossus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:OperatingIncomeLoss
us-gaap:ConsolidationItems
(None,)
Operating Income Lossus-gaap: Consolidation Items
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:Goodwill
us-gaap:StatementBusinessSegments
(None,)
Goodwillus-gaap: Statement Business Segments
us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
(None,)
Finite Lived Intangible Assets Netus-gaap: Finite Lived Intangible Assets By Major Class
us-gaap:OtherAssetsNoncurrent
us-gaap:BalanceSheetLocation
(None,)
Other Assets Noncurrentus-gaap: Balance Sheet Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:DepreciationDepletionAndAmortization
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Depreciation Depletion And Amortizationus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None, 'srdx:InVitroDiagnostics')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Product Or Service, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None, 'srdx:MedicalDevice')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Product Or Service, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Statement Business Segments